openPR Logo
Press release

Womens Health Diagnostics Market Growing $21,501 Million In 2023

12-27-2017 03:15 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Womens Health Diagnostics Market Growing $21,501 Million

The global women’s health diagnostics market was valued at $13,133 million in 2016, and is projected to reach $21,501 million in 2023 at a CAGR of 7.0% from 2017 to 2023. Women are more prone to obesity and reproduction related issues as compared to men. Women’s health diagnostics include screening, testing or diagnosing, and monitoring of several women-related disorders namely breast cancer, ovarian, cancer, cervical cancer, menopause, and pregnancy.

For More Info, Get Sample : http://bit.ly/2DjhNub

Rise in number of chronic and lifestyle disorders, which lead to various cancer such as breast cancer is the major factor that contributes to the growth of the women’s health diagnostics market. Moreover, rise in diabetic population, increase in geriatric population, and introduction of novel drugs to control symptoms such as nausea and vomiting fuel the market growth. However, side effects related to gastroparesis drugs, time-consuming regulatory process for the approval of drugs, and complications in gastroparesis diagnosis hamper the growth of the market. Conversely, surge in demand for the development of user-friendly drugs, rise in healthcare infrastructure, and creative marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.

The global women’s health diagnostics market is segmented on the basis of type, end user, and region. By type, it is classified into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound imaging systems, mammography systems, MRI systems, and nuclear imaging. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. Diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening and carrier testing includes tests for cystic fibrosis and other diseases. The pregnancy and ovulation testing segment is further bifurcated into lab-based pregnancy and ovulation testing, and home-based pregnancy and ovulation testing. Depending on end user, it is categorized into hospitals and clinics, home care settings, diagnostic and imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the global women’s health diagnostics market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Enquire About Report : http://bit.ly/2pJlvv1

KEY MARKET SEGMENTS

By Type

• Diagnostic Devices
• Biopsy Devices
• Imaging and Monitoring System
• Ultrasound Devices
• OB/GYN Ultrasound
• Breast Ultrasound
• Mammography Systems
• Analog Mammography
• Digital Mammography
• Breast Tomosynthesis
• MRI Systems
• Nuclear Imaging
• Diagnostic Tests
• Breast Cancer Testing
• Hormone Receptor Test
• Immunohistochemistry (IHC) Test
• Other Tests
• Cervical Cancer Testing
• PAP Smear (PAP) Test
• HPV Test
• Prenatal Genetic Screening and Carrier Testing
• Cystic Fibrosis
• Other Diseases
• Pregnancy and Ovulation Testing
• Lab-based Pregnancy and Ovulation Testing
• Home Based Pregnancy and Ovulation Testing
• Ovarian Cancer Testing
• Accessories and Consumables

By End User

• Hospitals and Clinics
• Home Care Settings
• Diagnostic and Imaging Centers
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Also Request For Discount : http://bit.ly/2CbRIxE

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Abbott Laboratories
• Becton, Dickinson and Company
• Carestream Health
• F. Hoffmann-La Roche AG
• GE Healthcare
• Hologic, Inc.
• Koninklijke Philips N.V.
• Quest Diagnostics Inc.
• Siemens AG
• Cardinal Health

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

• Cook Medical Incorporated
• C. R. Bard, Inc.
• MedGyn Products, Inc.
• Thermo Fisher Scientific

Table Of Content

• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE
• CHAPTER 5 WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER
• CHAPTER 7 COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Womens Health Diagnostics Market Growing $21,501 Million In 2023 here

News-ID: 877518 • Views: 587

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for Test

Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption
Global Mechanical Test Equipment Industry Global Mechanical Test Equipment Indus …
This study focuses on the production side and consumption side of Mechanical Test Equipment, presents the global Mechanical Test Equipment market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. In terms of production side, this report researches the Mechanical Test Equipment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type. In terms of
Test Automation Market
Test automation is being utilized in software for comparing the tangible outcomes with expected software outcomes. Automatically, there are various tools that help in operation of controlling the test execution. Software testing which is done manually through which person operates on the computer and go through several stages needed for testing purpose such as trying various usage, application screens, and input combinations that compares the results to be projected behavior
Test Series for Gate
As the market is not only based on talent any more but demands smart brains scoring stupendous. As just being a graduate from a simple or less renowned college does not make you stand in the market that demands highly educated and professional citizens people are switching themselves for higher education to reputed university and the entrance gate for reputed colleges are only through exams like GATE. People are spending
immigration DNA Test In
Immigration Dna Test in India Advanced DNA offer Paternity, Maternity, Siblings, Immigration Dna Test etc. in India. We offer a wide range of testing methods available for establishing a biological relationship for immigration, which include both paternity, and maternity testing. However other relationships can be proved between Siblings, Aunts/Uncles, Nieces/Nephews and Grandparents through our Relationship Testing. What Is The Process I Need To Follow for an Immigration Test? Advanced DNA India our Immigration department
itelligence wins ERP test
SAP consulting house wins first place Bielefeld (Germany), June 12, 2009 – In a comparison for ERP systems, GPS Gesellschaft für Prüfung von Software mbH and MQ result consulting AG tested the state of technology for 2009. With its it.manufacturing solution, the SAP consulting house itelligence won first place in multi-site solutions for ERP systems with the best rating – both from the technical jury as well as from the public. On